These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7098495

  • 1. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference.
    Dorris RL.
    J Pharmacol Methods; 1982 Mar; 7(2):133-7. PubMed ID: 7098495
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS, Lee SS, Lee KS, Lee MK.
    Life Sci; 2001 Dec 28; 70(6):639-45. PubMed ID: 11833714
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 28; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

  • 4. Rat and human cardiac monoamine oxidase: a comparison with other tissues.
    Dial EJ, Clarke DE.
    Eur J Pharmacol; 1979 Oct 01; 58(3):313-9. PubMed ID: 510362
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
    Lee SS, Lee JJ, Cheong MJ, Kim YH, Kim Y, Yun YP, Lee CK, Lee MK.
    Biol Pharm Bull; 2001 Jul 01; 24(7):838-40. PubMed ID: 11456127
    [Abstract] [Full Text] [Related]

  • 6. Observations on the monamine oxidase activity of rat vasa deferentia, major blood vessels and human saphenous vein.
    Dial EJ, Clarke DE.
    Res Commun Chem Pathol Pharmacol; 1977 May 01; 17(1):145-56. PubMed ID: 877399
    [Abstract] [Full Text] [Related]

  • 7. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M, Nomura Y, Ishiki R, Suzuki H, Nagatsu T.
    Neurosci Lett; 1987 Jun 15; 77(2):215-20. PubMed ID: 3601232
    [Abstract] [Full Text] [Related]

  • 8. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM, Du GH.
    Acta Pharmacol Sin; 2006 Jun 15; 27(6):760-6. PubMed ID: 16723097
    [Abstract] [Full Text] [Related]

  • 9. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M, Nagatsu T.
    Life Sci; 1987 Mar 16; 40(11):1075-82. PubMed ID: 3821373
    [Abstract] [Full Text] [Related]

  • 10. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M, Nomura Y, Ishiki R, Suzuki H, Nagatsu T.
    J Neurochem; 1988 Jan 16; 50(1):243-7. PubMed ID: 3335842
    [Abstract] [Full Text] [Related]

  • 11. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
    Rao KS, Rao GV.
    Mol Cell Biochem; 1994 Aug 17; 137(1):57-60. PubMed ID: 7845378
    [Abstract] [Full Text] [Related]

  • 12. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
    Arai R, Kimura H, Nagatsu I, Maeda T.
    Brain Res; 1997 Jan 16; 745(1-2):352-6. PubMed ID: 9037433
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T, Satoh S, Satoh N, Kisara K, Arai Y, Kim SK, Kinemuchi H.
    J Pharmacol Exp Ther; 1989 Jul 16; 250(1):254-60. PubMed ID: 2501477
    [Abstract] [Full Text] [Related]

  • 14. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN, LeDuc BW, Khan AA.
    Eur J Drug Metab Pharmacokinet; 2017 Oct 16; 42(5):827-834. PubMed ID: 28185143
    [Abstract] [Full Text] [Related]

  • 15. Properties of monoamine oxidase in monkey heart.
    Katayama M, Kobayashi S, Oguchi K, Yasuhara H.
    Jpn J Pharmacol; 1984 Aug 16; 35(4):425-31. PubMed ID: 6438377
    [Abstract] [Full Text] [Related]

  • 16. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW, Wong CJ, Hemrick-Luecke SK.
    Life Sci; 1986 Feb 03; 38(5):409-12. PubMed ID: 3945167
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z, Hroudová J, Raboch J.
    Neuro Endocrinol Lett; 2010 Feb 03; 31(5):645-56. PubMed ID: 21200377
    [Abstract] [Full Text] [Related]

  • 18. Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants.
    Herraiz T, Flores A, Fernández L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan 15; 1073():136-144. PubMed ID: 29268246
    [Abstract] [Full Text] [Related]

  • 19. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 15; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 20. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
    Nandigama RK, Miller JR, Edmondson DE.
    Biochemistry; 2001 Dec 11; 40(49):14839-46. PubMed ID: 11732903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.